CLOS
Compagnie Lombard Odier SCmA Portfolio holdings
AUM
$7.58B
1-Year Return
23.11%
This Quarter Return
+9.36%
1 Year Return
+23.11%
3 Year Return
+107.08%
5 Year Return
+161.87%
10 Year Return
+392.97%
AUM
$4.55B
AUM Growth
+$13.2M
(+0.29%)
Cap. Flow
-$381M
Cap. Flow
% of AUM
-8.38%
Top 10 Holdings %
Top 10 Hldgs %
40.85%
Holding
752
New
71
Increased
111
Reduced
146
Closed
86
Top Buys
| 1 |
Salesforce
CRM
|
+$49.1M |
| 2 |
Blackrock
BLK
|
+$26.4M |
| 3 |
Sea Limited
SE
|
+$23.5M |
| 4 |
ServiceNow
NOW
|
+$22.9M |
| 5 |
Estee Lauder
EL
|
+$19.9M |
Top Sells
| 1 |
Intellia Therapeutics
NTLA
|
+$45.8M |
| 2 |
Apellis Pharmaceuticals
APLS
|
+$23.8M |
| 3 |
Tandem Diabetes Care
TNDM
|
+$22.2M |
| 4 |
Moderna
MRNA
|
+$19.8M |
| 5 |
Allogene Therapeutics
ALLO
|
+$18.9M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Communication Services | 18.56% |
| 3 | Financials | 15.44% |
| 4 | Consumer Discretionary | 14.23% |
| 5 | Healthcare | 14.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Ford
F
$45.2B
| $245K | 0.01% |
+16,500
| New | +$245K |
|
302
Franco-Nevada
FNV
$38.2B
| $245K | 0.01% |
1,681
| – | – |
|
303
Topgolf Callaway Brands
MODG
$1.68B
| $245K | 0.01% |
+7,250
| New | +$245K |
|
304
Huntington Ingalls Industries
HII
$10.5B
| $240K | 0.01% |
1,140
-225
| -16% | -$47.4K |
|
305
Wendy's
WEN
$1.87B
| $239K | 0.01% |
+10,225
| New | +$239K |
|
306
Etsy
ETSY
$5.66B
| $238K | 0.01% |
+1,158
| New | +$238K |
|
307
Omnicom Group
OMC
$14.7B
| $237K | 0.01% |
2,960
| – | – |
|
308
Denali Therapeutics
DNLI
$2.17B
| $235K | 0.01% |
3,000
| – | – |
|
309
Akamai
AKAM
$11.1B
| $233K | 0.01% |
2,000
| – | – |
|
310
GT Biopharma
GTBP
$2.88M
| $233K | 0.01% |
+500
| New | +$233K |
|
|
CIT
311
DELISTED
CIT Group Inc.
CIT
| $232K | 0.01% |
4,504
| – | – |
|
312
Ally Financial
ALLY
$12.6B
| $229K | 0.01% |
4,595
| – | – |
|
313
Emerson Electric
EMR
$75.2B
| $227K | 0.01% |
2,356
| – | – |
|
314
Vulcan Materials
VMC
$38.8B
| $226K | 0.01% |
1,300
-700
| -35% | -$122K |
|
315
Morgan Stanley
MS
$244B
| $225K | ﹤0.01% |
2,466
+1,666
| +208% | +$152K |
|
316
ARK Fintech Innovation ETF
ARKF
$1.36B
| $224K | ﹤0.01% |
4,150
+300
| +8% | +$16.2K |
|
317
Novavax
NVAX
$1.29B
| $223K | ﹤0.01% |
1,050
-65,852
| -98% | -$14M |
|
318
Enlivex Therapeutics
ENLV
$24.1M
| $220K | ﹤0.01% |
25,000
| – | – |
|
319
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$15.1B
| $218K | ﹤0.01% |
+3,600
| New | +$218K |
|
320
KKR & Co
KKR
$124B
| $214K | ﹤0.01% |
+3,615
| New | +$214K |
|
321
iShares Core MSCI Emerging Markets ETF
IEMG
$105B
| $210K | ﹤0.01% |
+3,139
| New | +$210K |
|
322
Becton Dickinson
BDX
$53.9B
| $209K | ﹤0.01% |
882
+574
| +186% | +$136K |
|
323
Dave & Buster's
PLAY
$761M
| $209K | ﹤0.01% |
5,147
| – | – |
|
|
NEWR
324
DELISTED
New Relic, Inc.
NEWR
| $209K | ﹤0.01% |
3,120
| – | – |
|
325
Eli Lilly
LLY
$673B
| $207K | ﹤0.01% |
905
| – | – |
|